Impact of COVID-19 vaccination in post-COVID cardiac complications

[1]  Simon S. Martin,et al.  Long-term cardiac pathology in individuals with mild initial COVID-19 illness , 2022, Nature Network Boston.

[2]  A. Nasrullah,et al.  COVID-19 Vaccine and Long COVID: A Scoping Review , 2022, Life.

[3]  N. Kootstra,et al.  The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study , 2022, Vaccine.

[4]  G. McComsey,et al.  The Protective Effect of Coronavirus Disease 2019 (COVID-19) Vaccination on Postacute Sequelae of COVID-19: A Multicenter Study From a Large National Health Research Network , 2022, Open forum infectious diseases.

[5]  Benjamin Bowe,et al.  Long-term cardiovascular outcomes of COVID-19 , 2022, Nature Medicine.

[6]  J. Mossong,et al.  Risk reduction of severe outcomes in vaccinated COVID-19 cases: an analysis of surveillance data from Estonia, Ireland, Luxembourg and Slovakia, January to November 2021 , 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[7]  OUP accepted manuscript , 2022, European Heart Journal.

[8]  J. Gottenberg,et al.  Effect of SARS-CoV-2 Vaccination on Symptoms from Post-Acute Sequelae of COVID-19: Results from the Nationwide VAXILONG Study , 2021, Vaccines.

[9]  K. Khunti,et al.  Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection , 2021, Nature Medicine.

[10]  Jue Liu,et al.  Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis , 2021, Infectious Diseases of Poverty.

[11]  Bruno Lewin,et al.  Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older. , 2021, JAMA internal medicine.

[12]  J. Nelson,et al.  Surveillance for Adverse Events After COVID-19 mRNA Vaccination. , 2021, JAMA.

[13]  Kyunghwa Han,et al.  Prevalence of abnormal cardiovascular magnetic resonance findings in recovered patients from COVID-19: a systematic review and meta-analysis , 2021, Journal of Cardiovascular Magnetic Resonance.

[14]  Ben Y. Reis,et al.  Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting , 2021, The New England journal of medicine.

[15]  P. Edison,et al.  Long covid—mechanisms, risk factors, and management , 2021, BMJ.

[16]  P. Hotez,et al.  Myocarditis With COVID-19 mRNA Vaccines , 2021, Circulation.

[17]  S. Yong.  Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments , 2021, Infectious diseases.

[18]  N. Nanda,et al.  Echocardiography, lung ultrasound, and cardiac magnetic resonance findings in COVID‐19: A systematic review , 2021, Echocardiography.

[19]  Tung Hoang,et al.  Comparison of Comorbidities in Relation to Critical Conditions among Coronavirus Disease 2019 Patients: A Network Meta-Analysis , 2021, Infection & chemotherapy.

[20]  M. Huerín,et al.  Cardiovascular involvement and its relationship with the severity of the acute phase and persistent symptoms during recovery from COVID-19 infection , 2021 .

[21]  P. Kirchhof,et al.  Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. , 2020, JAMA cardiology.

[22]  Eike Nagel,et al.  Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.

[23]  Angelo Carfì,et al.  Persistent Symptoms in Patients After Acute COVID-19. , 2020, JAMA.

[24]  H. Krumholz,et al.  Extrapulmonary manifestations of COVID-19 , 2020, Nature Medicine.

[25]  Kipp W. Johnson,et al.  Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection , 2020, Journal of the American College of Cardiology.

[26]  L. Cooper,et al.  Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management , 2020, Heart Rhythm.

[27]  F. Crea,et al.  COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options , 2020, Cardiovascular research.

[28]  Hongliang Li,et al.  The Science Underlying COVID-19: Implications for the Cardiovascular System. , 2020, Circulation.

[29]  Mohammad Madjid,et al.  Potential Effects of Coronaviruses on the Cardiovascular System: A Review. , 2020, JAMA cardiology.

[30]  W. Gong,et al.  Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. , 2020, JAMA cardiology.

[31]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[32]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[33]  E. Holmes,et al.  A new coronavirus associated with human respiratory disease in China , 2020, Nature.

[34]  C. E..  WHO Coronavirus Disease (COVID-19) Dashboard , 2020 .

[35]  J. Luban.  SARS-CoV-2 , 2020 .

[36]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.